Finally, although all patients benefited from standard-of-care treatments, we observed a trend towards increased survival in patients treated with tocilizumab; however, this did not reach statistical significance.
← all excerpts
High-flow cannula for frail patients with SARS-CoV-2 infection non-eligible for intensive care unit management.
1
—
—